Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-28

Clinical Trial Update: Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Anakinra plus zinc versus prednisone in severe alcoholic hepatitis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anakinra (anakinra)
  • PREDNISONE (Prednisone)
  • ZINC (Zinc chloride)

Snippet

Sponsor: Indiana University | Conditions: Alcoholic Hepatitis | Phase 2 | Status: COMPLETED | Results posted: 2023-07-28